Wapenveld, Netherlands

Igor Mierau

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Aurealis Oy. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Igor Mierau. Retrieved from https://idiyas.com/inventor/igor-mierau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Igor Mierau: Innovator in Probiotic Bacteria

Introduction

Igor Mierau is a notable inventor based in Wapenveld, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant probiotic bacteria. His work focuses on innovative solutions for treating inflammatory skin dysfunctions.

Latest Patents

Igor Mierau holds a patent for recombinant probiotic bacteria. This invention is specifically directed towards the treatment of inflammatory skin dysfunctions. The patent also includes a method for effectively treating such conditions, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Igor has worked with several companies, including Aurealis Oy and Aurealis Therapeutics AG. His experience in these organizations has allowed him to refine his expertise in biotechnology and contribute to groundbreaking research.

Collaborations

Igor has collaborated with notable professionals in his field, including Thomas Wirth and Juha Yrjänheikki. These partnerships have further enhanced his work and expanded the impact of his inventions.

Conclusion

Igor Mierau's innovative work in recombinant probiotic bacteria represents a significant advancement in the treatment of inflammatory skin dysfunctions. His contributions to biotechnology continue to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…